Stockscreener 앱 받기
33.39
0.89%
-0.30
시장 영업 전:
34.22
0.83
+2.49%
전일 마감가:
$33.69
열려 있는:
$33.51
하루 거래량:
1.43M
Relative Volume:
0.69
시가총액:
$5.33B
수익:
$616.29M
순이익/손실:
$447.18M
주가수익비율:
12.02
EPS:
2.7771
순현금흐름:
$-24.99M
1주 성능:
+0.51%
1개월 성능:
+14.08%
6개월 성능:
-8.52%
1년 성능:
-10.36%
1일 변동 폭
$33.05
$33.89
1주일 범위
$33.05
$35.33
52주 변동 폭
$25.28
$46.48
TG테라퓨틱스사 Stock (TGTX) Company Profile
명칭
Tg Therapeutics Inc
전화
(212) 554-4484
주소
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Compare TGTX vs VRTX, REGN, ARGX, ALNY, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
33.39 | 5.33B | 616.29M | 447.18M | -24.99M | 2.7771 |
VRTX
Vertex Pharmaceuticals Inc
|
431.86 | 109.85B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
760.27 | 80.38B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
765.43 | 47.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
319.52 | 42.63B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.03 | 35.19B | 606.42M | -1.28B | -997.58M | -6.403 |
TG테라퓨틱스사 Stock (TGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-06 | 재개 | H.C. Wainwright | Buy |
| 2025-07-10 | 재개 | Goldman | Neutral |
| 2024-10-29 | 개시 | TD Cowen | Buy |
| 2023-08-02 | 업그레이드 | Goldman | Sell → Neutral |
| 2023-06-26 | 재개 | Jefferies | Buy |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-20 | 개시 | Goldman | Neutral |
| 2021-04-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-01 | 개시 | JP Morgan | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 개시 | Evercore ISI | Outperform |
| 2020-01-17 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-02-06 | 재개 | Jefferies | Buy |
| 2018-09-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 재개 | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 재개 | H.C. Wainwright | Buy |
| 2017-04-25 | 개시 | Jefferies | Buy |
| 2017-03-06 | 재확인 | FBR & Co. | Outperform |
| 2016-10-06 | 재개 | Brean Capital | Buy |
| 2016-05-27 | 개시 | SunTrust | Buy |
| 2015-12-01 | 개시 | FBR Capital | Outperform |
| 2015-09-09 | 개시 | Raymond James | Strong Buy |
| 2015-08-12 | 재개 | H.C. Wainwright | Buy |
| 2015-06-19 | 재확인 | Brean Capital | Buy |
| 2014-12-11 | 재확인 | ROTH Capital | Buy |
| 2014-12-10 | 재확인 | ROTH Capital | Buy |
모두보기
TG테라퓨틱스사 주식(TGTX)의 최신 뉴스
Fed Meeting: Can TG Therapeutics Inc expand into new marketsMarket Trend Report & Daily Momentum Trading Reports - baoquankhu1.vn
Gains Recap: Is TG Therapeutics Inc undervalued by DCF analysis - baoquankhu1.vn
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
TGTX PE Ratio & Valuation, Is TGTX Overvalued - intellectia.ai
TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum - ChartMill
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance UK
TG THERAPEUTICS INC (1TGTX.MI) Balance Sheet - Yahoo! Finance Canada
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Inc. (TGTX) Stock Price | Live Quotes & Charts | NASDAQ - stockstotrade.com
TGTX Stock Price, Quote & Chart | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
(TGTX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
TG Therapeutics, Inc. (TGTX) Stock Forecasts - finance.yahoo.com
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX) - Seeking Alpha
Analyst Calls: Is TG Therapeutics Inc undervalued by DCF analysis2026 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
TG Therapeutics, Inc. $TGTX Shares Bought by JPMorgan Chase & Co. - MarketBeat
TG Therapeutics stock price forecast: overbought readings persist as TGTX consolidates below SMA-200 - Traders Union
Nordea Investment Management AB Buys Shares of 79,696 TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
Vanguard disaggregates holdings after realignment — TG Therapeutics (TGTX) - stocktitan.net
TG THERAPEUTICS INC (1TGTX.MI) Stock Major Holders - Yahoo! Finance Canada
TG Therapeutics announces $100M share buyback program - MSN
US$750 Million Credit Facility Could Be A Game Changer For TG Therapeutics (TGTX) - simplywall.st
A Look At TG Therapeutics (TGTX) Valuation After New US$750 Million Credit Facility - Yahoo Finance
1,922,410 Shares in TG Therapeutics, Inc. $TGTX Acquired by Congress Asset Management Co. - marketbeat.com
TG Therapeutics (TGTX) reports financial results for Q4 and full year 2025 - MSN
Day Trade: Is TG Therapeutics Inc still a buy after recent gains2026 Review & Stepwise Trade Execution Plans - baoquankhu1.vn
CapEx per share of TG Therapeutics, Inc. – MIL:1TGTX - TradingView
TG Therapeutics Credit Deal And Valuation Gap Catch Investor Attention - simplywall.st
TG Therapeutics Files Procedural 8-K on Financial Obligation - The Globe and Mail
(TGTX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
TG Therapeutics, Inc. (TGTX) Enters $750 Million Term Loan Agreement – SEC 8-K Filing Summary - Minichart
Form 8K TG Therapeutics Inc For: 20 March By Investing.com - Investing.com Canada
Form 8K TG Therapeutics Inc For: 20 March - Investing.com
TG Therapeutics, Inc. Enters into First Amendment Agreement for $750 Million Term Loan Facility and $250 Million Uncommitted Additional Facility - marketscreener.com
TG Therapeutics (TGTX) secures $750M 2026 Term Loan maturing 2031 - Stock Titan
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2025 earnings call transcript - MSN
TG Therapeutics (TGTX) Secures $750 Million Credit Facility - GuruFocus
TG Therapeutics secures $750M credit facility with Blue Owl By Investing.com - Investing.com India
TG Therapeutics board expands share repurchase program to $300M - TipRanks
TG Therapeutics secures $750M credit facility with Blue Owl - investing.com
TG Therapeutics (TGTX) Secures $750M Credit Facility, Expands Sh - GuruFocus
TG Therapeutics Receives $500 Million in New Capital From Blue Owl, Increases Share Buyback - marketscreener.com
TG Therapeutics secures an additional $500 million in non-dilutive capital from Blue Owl and expands share repurchase program to $300 million - marketscreener.com
TG Therapeutics Secures An Additional $500 Million In Non-Dilutive Capital From Blue Owl And Expands Share Repurchase Program To $300 Million - TradingView
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million - The Manila Times
TG Therapeutics Secures an Additional $500 Million in - GlobeNewswire
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital From Blue Owl and Expands Share Repurchase Program to $300 Million - 富途牛牛
Penn Capital Management Company LLC Grows Stock Position in TG Therapeutics, Inc. $TGTX - MarketBeat
Is the options market predicting a spike in TG Therapeutics stock? - MSN
TG Therapeutics Analysis: Strong Clinical Data Boost Briumvi Prospects - timothysykes.com
TG Therapeutics (NASDAQ:TGTX) Shares Up 7.9%Here's What Happened - MarketBeat
TG테라퓨틱스사 (TGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
2.75%
자본화:
|
볼륨(24시간):